J B Chemicals and Pharmaceuticals Limited has announced its latest Environmental, Social and Governance (ESG) score from the Dow Jones Sustainability Index (DJSI), achieving a notable score of 86. This achievement positions the pharmaceutical company among the leading players in India's pharmaceutical sector and ranks it among global leaders in the DRG Pharmaceuticals sector according to DJSI and S&P Global.

DJSI ESG Performance

The company's performance in the sustainability assessment reflects its commitment to corporate responsibility and ESG excellence. The following table summarizes the key aspects of the DJSI evaluation:

Comprehensive Sustainability Assessment

The DJSI ranking represents a premier globally recognized benchmark for corporate sustainability. The evaluation process involves rigorous assessment covering Environmental, Social and Governance criteria through industry-specific questionnaires. The assessment framework evaluates an average of 23 sustainability topics through 150 questions and indicators, examining approximately 13,000 companies worldwide every year.

Sustainability Initiatives Implementation

Over the past year, J.B. Chemicals has implemented several impactful sustainability initiatives that contributed to this strong ESG performance:

• Renewable energy adoption programs
• Rainwater harvesting project implementation
• Waste reduction programs across operations
• Enhanced governance measures
• Community development projects

These comprehensive efforts have contributed to a positive environmental and social footprint while strengthening the company's position as a leader in sustainable growth.

Strategic ESG Integration

The company's DJSI score reflects its continuous efforts to integrate sustainable practices into core business operations. This achievement underscores J.B. Chemicals' steadfast commitment to sustainability, corporate responsibility, and environmental, social governance excellence. The strong performance in the globally recognized sustainability index demonstrates the company's dedication to maintaining high standards across all ESG parameters while pursuing business growth objectives.

J B Chemicals and Pharmaceuticals Limited has received a tax demand order of ₹4.01 crores from the Joint Commissioner of State Tax, Uttar Pradesh, related to disallowed Input Tax Credit during FY2021-22. The company plans to appeal against this order.

Tax Order Details

The pharmaceutical company received the order, which pertains to the disallowance of Input Tax Credit availed during the financial year 2021-22. The order details are as follows:

Company's Response and Impact Assessment

J B Chemicals and Pharmaceuticals has indicated that it maintains a strong case on merits and will prefer an appeal against the order. The company plans to challenge the tax demand, asserting its position on the disallowed input tax credit.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's proactive disclosure demonstrates its commitment to maintaining transparency with stakeholders regarding regulatory developments that could potentially affect its operations.